Data as of 11:58am ET
| +0.045 / +0.10%|
The 10 analysts offering 12-month price forecasts for Integra LifeSciences Holdings Corp have a median target of 49.50, with a high estimate of 57.00 and a low estimate of 40.00. The median estimate represents a +6.03% increase from the last price of 46.69.
The current consensus among 16 polled investment analysts is to Hold stock in Integra LifeSciences Holdings Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.